IJMS | Free Full-Text | Metabolomic Biomarkers in Gestational Diabetes Mellitus: A Review of the Evidence
A Map of Human Type 1 Diabetes Progression by Imaging Mass Cytometry - ScienceDirect
Temporal metabolic and transcriptomic characteristics crossing islets and liver reveal dynamic pathophysiology in diet-induced diabetes - ScienceDirect
Endocrines | Free Full-Text | Diabetic Ketoacidosis Management: Updates and Challenges for Specific Patient Population
Identification of potential markers for type 2 diabetes mellitus via bioinformatics analysis
Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) | SpringerLink
JCI Insight - Human duct cells contribute to β cell compensation in insulin resistance
Targeting inflammation in the treatment of type 2 diabetes: time to start | Nature Reviews Drug Discovery
Metabolic and proteomic signatures of type 2 diabetes subtypes in an Arab population | Nature Communications
IJMS | Free Full-Text | Insulin: The Friend and the Foe in the Development of Type 2 Diabetes Mellitus
Lentivirus Mediated Pancreatic Beta-Cell-Specific Insulin Gene Therapy for STZ-Induced Diabetes: Molecular Therapy
Frontiers | Biomarkers of autoimmunity and beta cell metabolism in type 1 diabetes
Pancreatic β Cell Dedifferentiation as a Mechanism of Diabetic β Cell Failure: Cell
Human Islet Expression Levels of Prostaglandin E2 Synthetic Enzymes, But Not Prostaglandin EP3 Receptor, Are Positively Correlated with Markers of β-Cell Function and Mass in Nondiabetic Obesity | ACS Pharmacology & Translational
Endocrines | Free Full-Text | Diabetic Ketoacidosis Management: Updates and Challenges for Specific Patient Population
IJMS | Free Full-Text | Stem Cell-Derived Islets for Type 2 Diabetes
Frontiers | Diabetic cardiomyopathy: Clinical phenotype and practice
IJMS | Free Full-Text | Current Knowledge on the Pathophysiology of Lean/Normal-Weight Type 2 Diabetes
Targeting innate immune mediators in type 1 and type 2 diabetes | Nature Reviews Immunology
IJMS | Free Full-Text | Sodium Glucose Cotransporter-2 Inhibitors: Spotlight on Favorable Effects on Clinical Outcomes beyond Diabetes
The Beta Cell in Type 2 Diabetes | SpringerLink
Understanding multifactorial brain changes in type 2 diabetes: a biomarker perspective - The Lancet Neurology
Strategies for durable β cell replacement in type 1 diabetes | Science
